Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 9;3(1):33-38.
doi: 10.14744/hf.2021.2021.0033. eCollection 2022 Jan.

Prevention of hepatocellular carcinoma and monitoring of high-risk patients

Eda Kaya  1   2 , Guillermo Daniel Mazzolini  3 , Yusuf Yilmaz  4   5 , Ali Canbay  1   2
Affiliations
Review

Prevention of hepatocellular carcinoma and monitoring of high-risk patients

Eda Kaya et al. Hepatol Forum. .

Abstract

Hepatocellular carcinoma (HCC) accounts for some 80% of primary liver tumors. According to recent data, HCC is the sixth most common type of cancer and the third leading cause of cancer-related mortality worldwide. Risk factors for HCC include the presence of the hepatitis B virus, hepatitis C virus, non-alcoholic fatty liver disease, and exposure to noxious agents, such as alcohol, or toxins, such as aflatoxin, which are considered preventable etiologies of HCC. Monitoring strategies are needed for patients at risk of developing HCC. There is a consensus on routine monitoring of cirrhotic patients due to definitive evidence of a significantly high rate of progression to HCC; however, the appropriate surveillance of patients with advanced fibrosis remains a topic of discussion. Nevertheless, adherence to a strict observation protocol is the cornerstone of early detection and treatment with curative options for patients with a high risk of developing HCC. This review examines prevention strategies, risk factors, and surveillance based on current guidelines.

Keywords: Hepatitis B; hepatitis C; hepatocellular carcinoma; non-alcoholic fatty liver disease; prevention; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflict of interest to declare.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–249. - PubMed
    1. Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. Epidemiology, genotype distribution, prognosis, control, and management of viral hepatitis b, c, d, and hepatocellular carcinoma in mongolia. Euroasian J Hepatogastroenterol. 2018;8(1):57–62. - PMC - PubMed
    1. Popp W, Gantumur T, Ross B, Zorigt K, Davaadorj D, Rossburg M, et al. Aflatoxin exposure may not play a role in liver cancer development in Mongolia. Digestion. 2014;89(4):268–71. - PubMed
    1. Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology. 2018;67(2):600–611. - PMC - PubMed
    1. Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, et al. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 2020;147(2):317–330. - PMC - PubMed

LinkOut - more resources